A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand

[1]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[2]  S. Tangye,et al.  2B4-mediated activation of human natural killer cells. , 2000, Molecular immunology.

[3]  S. Chouaib,et al.  Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. , 2000, Blood.

[4]  R. Biassoni,et al.  2B4 functions as a co‐receptor in human NK cell activation , 2000, European journal of immunology.

[5]  D. Speiser,et al.  Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression1 , 2000, The Journal of Immunology.

[6]  D. Speiser,et al.  In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes , 1999, The Journal of experimental medicine.

[7]  T. Spies,et al.  Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB , 1999 .

[8]  D. Speiser,et al.  CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients , 1999, European journal of immunology.

[9]  R. Negrin,et al.  Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. , 1998, Blood.

[10]  L. Moretta,et al.  Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. , 1998, Immunology today.

[11]  S. Bauer,et al.  Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. , 1998, Science.

[12]  R. Bellomo,et al.  HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Olive,et al.  Regulation of CD80/B7‐1 and CD86/B7‐2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition , 1998, European journal of immunology.

[14]  A. Fauci,et al.  Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Moretta,et al.  Expression of HLA class l‐specific inhibitory receptors by chronically activated cytolytic T lymphocytes: useful or harmful to the host? , 1997, Melanoma research.

[16]  R. Biassoni,et al.  HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. , 1997, International immunology.

[17]  A. Fauci,et al.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Bahram,et al.  Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Mingari,et al.  HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. , 1996, Chemical immunology.

[20]  P. Parham,et al.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.

[21]  S. Ferrini,et al.  Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. , 1995, International immunology.

[22]  S. Sforzini,et al.  T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function , 1994, European journal of immunology.

[23]  T. Loughran,et al.  Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. , 1994, Blood.

[24]  R. Negrin,et al.  A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. , 1994, Journal of immunology.

[25]  M. Bennett,et al.  Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[26]  G. Trinchieri,et al.  Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes , 1993, The Journal of experimental medicine.

[27]  A. Purohit,et al.  A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[28]  D. Olive,et al.  The CD2 and CD28 adhesion molecules induce long‐term autocrine proliferation of CD4+ T cells , 1993, European journal of immunology.

[29]  F. Mami-Chouaib,et al.  TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1 , 1991, The Journal of experimental medicine.

[30]  M. Amiot,et al.  Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. , 1991, Journal of immunology.

[31]  G. Pantaleo,et al.  Surface Molecules Involved in the Activation and Regulation of T or Natural Killer Lymphocytes in Humans , 1989, Immunological reviews.

[32]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[33]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[34]  D. Speiser,et al.  The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells. , 2001, Journal of immunology.

[35]  D. Olive,et al.  Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets , 2000, Leukemia.

[36]  R. Bellomo,et al.  Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. , 2000, Human immunology.

[37]  S. Bauer,et al.  Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Ciccone,et al.  Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery. , 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.